These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 11020900

  • 1. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
    Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF.
    Hepatogastroenterology; 2000; 47(34):1147-50. PubMed ID: 11020900
    [Abstract] [Full Text] [Related]

  • 2. Results of treating severe acute pancreatitis with gabexate is associated with neutrophil apoptosis activity.
    Chiu DF, Chen JC, Chen HM, Ng CJ, Shyr MH, Chen MF.
    Hepatogastroenterology; 2003; 50(50):553-8. PubMed ID: 12749271
    [Abstract] [Full Text] [Related]

  • 3. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
    Chen CC, Wang SS, Tsay SH, Lee FY, Lu RH, Chang FY, Lee SD.
    Cytokine; 2006 Jan 21; 33(2):95-9. PubMed ID: 16473521
    [Abstract] [Full Text] [Related]

  • 4. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J, Melzer P, Schmidt FW, Horbach L.
    Z Gastroenterol; 1986 Apr 21; 24(4):200-11. PubMed ID: 3087076
    [Abstract] [Full Text] [Related]

  • 5. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
    Kimura K, Tominaga K, Fujii M, Saito T, Kasai H.
    Arzneimittelforschung; 1998 Jan 21; 48(1):65-9. PubMed ID: 9522035
    [Abstract] [Full Text] [Related]

  • 6. Continuous regional arterial infusion therapy for acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection in a child.
    Nakagawa M, Ogino H, Shimohira M, Hara M, Shibamoto Y.
    Cardiovasc Intervent Radiol; 2009 May 21; 32(3):581-4. PubMed ID: 18956223
    [Abstract] [Full Text] [Related]

  • 7. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
    Pezzilli R, Gabbrielli A, Labate AM, D'Alessio P, Barakat B, Costamagna G, Dibenedetti F, Massa M, Merlini G, d'Eril GM.
    Hepatogastroenterology; 2003 May 21; 50(51):851-5. PubMed ID: 12828103
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G, Ardizzone S, Lombardi G, Uomo G, Pieramico O, Porro GB.
    Gastrointest Endosc; 2007 Jun 21; 65(7):982-7. PubMed ID: 17531632
    [Abstract] [Full Text] [Related]

  • 9. [Increased intra-abdominal pressure--an important risk factor of early organ dysfunction in severe acute pancreatitis].
    Pupelis G, Autrums E, Snippe K, Melbarde-Gorkusa I.
    Zentralbl Chir; 2002 Nov 21; 127(11):982-6. PubMed ID: 12476373
    [Abstract] [Full Text] [Related]

  • 10. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M, Chen Y, Yang X, Li J, Zhang Y, Zeng Q.
    BMC Gastroenterol; 2007 Feb 12; 7():6. PubMed ID: 17295917
    [Abstract] [Full Text] [Related]

  • 11. [Importance of a clinical protocol in the treatment of severe acute pancreatitis].
    Pupelis G, Austrums E, Snippe K.
    Zentralbl Chir; 2002 Nov 12; 127(11):975-81. PubMed ID: 12476372
    [Abstract] [Full Text] [Related]

  • 12. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
    Heitz J, Semsch B, Emde C, Jansen U, Schäfer JH.
    Z Gastroenterol; 1990 Apr 12; 28(4):192-7. PubMed ID: 2119091
    [Abstract] [Full Text] [Related]

  • 13. Multicentre comparative study of two schedules of gabexate mesilate in the treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group.
    Pezzilli R, Miglioli M.
    Dig Liver Dis; 2001 Apr 12; 33(1):49-57. PubMed ID: 11303975
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of gabexate mesilate for acute pancreatitis in children.
    Kim SC, Yang HR.
    Eur J Pediatr; 2013 Nov 12; 172(11):1483-90. PubMed ID: 23812506
    [Abstract] [Full Text] [Related]

  • 15. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.
    Masci E, Cavallini G, Mariani A, Frulloni L, Testoni PA, Curioni S, Tittobello A, Uomo G, Costamagna G, Zambelli S, Macarri G, Innocenti P, Dragonetti C, Gabexate in Digestive Endoscopy-Italian Group II.
    Am J Gastroenterol; 2003 Oct 12; 98(10):2182-6. PubMed ID: 14572565
    [Abstract] [Full Text] [Related]

  • 16. [Gabexate mesilate vs gabexate mesilate combined with octreotide in the prevention of postoperative complications of pancreatic surgery: preliminary results].
    Bonora A, Bassi C, Falconi M, Sartori N, De Santis L, Dragonetti C, Innocenti P, Pederzoli P.
    Chir Ital; 2001 Oct 12; 53(1):65-72. PubMed ID: 11280830
    [Abstract] [Full Text] [Related]

  • 17. Gabexate mesilate in the treatment of acute pancreatitis.
    Pederzoli P, Bassi C, Falconi M, De Santis L, Uomo G, Rabitti PG, Talamini G, Cavallini G.
    Ann Ital Chir; 1995 Oct 12; 66(2):191-5. PubMed ID: 7545361
    [Abstract] [Full Text] [Related]

  • 18. The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats.
    Chen HM, Hwang TL, Chen MF.
    J Surg Res; 1996 Dec 12; 66(2):147-53. PubMed ID: 9024827
    [Abstract] [Full Text] [Related]

  • 19. Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
    Mikami K, Goto T, Miura K, Ohshima S, Yoneyama K, Lin JG, Watanabe D, Segawa D, Kataoka E, Shibuya T, Watanabe S.
    J Gastroenterol; 2005 Mar 12; 40(3):260-5. PubMed ID: 15830285
    [Abstract] [Full Text] [Related]

  • 20. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
    Testoni PA, Mariani A, Masci E, Curioni S.
    Dig Liver Dis; 2006 Aug 12; 38(8):588-95. PubMed ID: 16731060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.